“23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, was told by U.S. regulators to halt sales of its main product because it’s being sold without ‘marketing clearance or approval.’ The Saliva Collection Kit and Personal Genome Service, or PGS, tells users whether they carry a disease, are at risk of a disease and would respond to a drug. Most of the uses fall into the category of a medical device and require Food and Drug Administration approval, the agency told the Mountain View, California-based company in a Nov. 22 letter made public today.”
Related posts:
Heart Surgery in India for $1,583 Costs $106,385 in U.S.
Thai PM uses cardboard cutout to avoid questions
Al Gore has thrived as green-tech investor
Supreme Court rules in favor of Florida property owner over denied development permit
iPhone 5S fingerprint reader manages to remain secure for almost 3 days
US steps up efforts to break Guantánamo hunger strike
Obama, Republicans gear up for bruising U.S. budget fight
West Sacramento Police officer in custody in sex assault, kidnap charges
Now the taxman is spying on your home using Google Earth
496 Uber cars seized by NYC taxi police amid crackdown
African Bank rescue rekindles bailout fears
FATCA: The end of financial privacy
Police issue warning over new Canadian bank notes as counterfeits flood in
Mongolia looks for second chance with foreign investors
‘Find a safe haven,’ father tells Snowden in Russia